CIK 0001472091
- Non-accelerated filer
- Smaller reporting company
PDS Biotechnology Corp
Sign in to watch- Ticker
- PDSB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 264231384
- Phone
- +1 800-208-3343
- Business address
- 303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- Edge Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 27 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-14 | Saik Andrew Chief Financial Officer | Grant or award | +38,400 | $1.30 | $50K | 42,549 |
| 2019-06-06 | Saik Andrew Chief Financial Officer | Grant or award · Stock Option (Right To Purchase) | +62,715 | 62,715 | ||
| 2019-03-15 | Saik Andrew Chief Financial Officer | Option exercise | +82,999 | 82,999 | ||
| 2019-03-15 | Saik Andrew Chief Financial Officer | Option exercise · Restricted Stock Units | −82,999 | 0 | ||
| 2018-08-14 | Saik Andrew Chief Financial Officer | Grant or award · Restricted Stock Units | +82,999 | 82,999 | ||
| 2018-06-19 | Saik Andrew Chief Financial Officer | Grant or award · Stock Option (Right To Purchase) | +166,001 | 166,001 | ||
| 2018-03-01 | Saik Andrew Chief Financial Officer | Grant or award · Stock Option (Right To Purchase) | +50,000 | 50,000 | ||
| 2017-11-01 | Saik Andrew Chief Financial Officer | Grant or award · Stock Option (Right To Purchase) | +200,000 | 200,000 |
Page 1 of 1 · 8 trades